Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4. (2020)
Attributed to:
Confidence in Concept 2012 - Imperial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-020-68907-1
PubMed Identifier: 32694738
Publication URI: http://europepmc.org/abstract/MED/32694738
Type: Journal Article/Review
Volume: 10
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322